1 0 Due to the extensive antigenic diversity of HIV-1, broadly neutralizing antibodies (bnAbs) develop in a 1 1 subset of infected individuals over 2-3 years of infection 1,2 . Interestingly, infected infants have been 1 2 shown to develop plasma bnAbs frequently and as early as one-year post-infection 3 , with features 1 3 atypical than adult bnAbs 4,5 , suggesting the factors governing bnAb induction in infants are different 1 4 than those in adults. Understanding the antigenic features in infants with early bnAb responses will 1 5 provide key information on the antigenic triggers driving B cell maturation pathways towards induction 1 6 of bnAbs. Herein, we evaluated the presence of plasma bnAbs in HIV-1 clade C perinatally infected 1 7 infants of Indian origin and identified the viral factors associated with early bnAb responses. A strong 1 8 association of multivariant infection in infant elite neutralizers with development of plasma nAbs 1 9
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diversity in the context of bnAb induction, we performed SGA analysis of env sequences 16 (V1C5 7 2 region of HIV-1 gp120) from circulating viral variants in ENs and BNs to assess the impact of viral 7 3 diversity on bnAb induction. From each sample, more than 30 env sequences were generated, giving 7 4 a 90% confidence interval of sequencing variants present at 10% population frequency. Maximum 7 5 likelihood phylogeny and pairwise raw distance distribution were assessed to identify the pattern of 7 6 viral transmission and intra-host diversity. Of the four ENs, three showed multivariant HIV-1 infection 7 7 (two distinct branches on phylogeny tree 17 ), with one infant, AIIMS709, showing two highly divergent 7 8 variants, plausibly due to superinfection, that needs to be further explored (Figure 3A, 
9
Supplementary Figure 3 -4) . The SGA env sequences from BNs were monophyletic, with long 8 0 branch lengths in some cases, suggestive of highly diverse infecting viruses ( Figure 3A) . In addition, 8 1 high evolutionary divergence was observed in ENs compared to BNs (p = 0.006) (Figure 3B -C, 8 2 Supplementary Table 2 ). Moreover, the multivariant infection in this infant cohort was significantly 8 3 associated (odds ratio >35, p = 0.043) with development of plasma breadth, though a small sample 8 4 size might have skewed the association. HIV-1 multivariant infection is defined as one person infected 8 5 with two or more different HIV-1 strains. According to the timing of infection with the second strain, 8 6 multivariant infections can be divided into co-infection 18 (acquisition of a second strain either 8 7 4 simultaneously or before seroconversion) and superinfection 19, 20 (acquisition of a second strain after 8 8 seroconversion), but given the cross-sectional nature of this study, we could only categorize the 8 9 multivariant infections as co-infection.
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Multivariant HIV-1 infection is more commonly seen in adults than in children who have acquired the 9 1 infection by vertical transmission 16, 17, 21, 22 . The stringent genetic bottleneck for transmission in 9 2 perinatally infected infants often leads to infection by a single viral variant 23 . To gain insight and 9 3 evaluate the impact of multivariant infection in development of plasma nAbs, we next generated 9 4
functional pseudoviruses from all four ENs. The generated pseudoviruses were tested for 9 5 neutralization by autologous nAbs. Distinct viral populations in each of the infected infant showed 9 6
varied susceptibility to autologous plasma nAbs, with several variant sensitive and others moderately 9 7 sensitive to autologous plasma bnAbs ( Figure 3D) , an observation we previously reported to be the 9 8 driver of elite plasma neutralization activity 8 . Pseudoviruses were then probed for their susceptibility to 9 9
known bnAbs, and non-nAbs to assess their antigenic profile and potential as candidate components bnAbs still remains to be explored.
5
have been less explored due to immunodominance of HIV-1 which in turn can diminish the efficacy of 1 1 8 vaccines 29, 30 . We observed the plasma nAbs in infants with multivariant infection to target both 1 1 9
variants, suggesting env specific antibodies generated in context of two distinct viral variants can 1 2 0 target epitopes on both envelopes. In addition, viral variants from these infants can be explored as plates were incubated for 48h at 37 o C, cells were lysed in presence of Bright Glow reagent, and 1 5 0 luminescence was measured. Using the luminescence of serially diluted bnAbs or plasma, a non-1 5 1 linear regression curve was generated and titres were calculated as the bnAb concentration, or 1 5 2 reciprocal dilution of serum that showed 50% reduction in luminescence compared to untreated virus 1 5 3 control. For plasma samples, percent neutralization for each plasma-virus combination was recorded 1 5 4
as a breadth-potency matrix at a fixed dilution of 1/50: >80% neutralization received a score of 3, 1 5 5 >50% a score of 2, >20% a score of 1, and <20 received a score of 0. Maximum cumulative score for 1 5 6 a given plasma was 60, and neutralization score was given as the ratio of cumulative score for 1 5 7
respective plasma to the maximum cumulative score, providing neutralization score on a continuous The SGA amplified HIV-1 envelope sequences have been submitted to GenBank. Accession numbers 1 7 8
will be provided once available.
7 9
Cloning of autologous HIV-1 envelope genes and production of replication incompetent 
8 8
Pseudoviruses were prepared by co-transfecting 1.25 µg of HIV-1 envelope containing plasmid with 1 8 9 2.5 µg of an envelope deficient HIV-1 backbone (PSG3Δenv) vector at a molar ratio of 1:2 using PEI-1 9 0 MAX as transfection reagent in HEK293T cells seeded in a 6-well culture plates. Culture supernatants 1 9 1 containing pseudoviruses were harvested 48 hours post-transfection, filtered through 0.4µ filter, 1 9 2 aliquoted and stored at -80 o C until further use. TCID50 was determined by infecting TZM-bl cells with 1 9 3 serially diluted pseudoviruses in presence of DEAE-Dextran, and lysing the cells 48 hours post-1 9 4
infection. Infectivity titres were determined by measuring luminescence activity in presence of Bright 1 9 5
Glow reagent (Promega).
9 6
Statistical analysis 1 9 7
Mann-Whitney U test and Kruskal-Wallis test were used for comparison of two and three parameters 1 9 8
respectively. All statistical analyses were performed on GraphPad Prism 8. A p-value of <0.05 was 1 9 9 considered significant. 
